Dr. Patel on the Benefits of a Multidisciplinary Approach for Patients With Stage III Lung Cancer

Video

Jyoti D. Patel, MD, thoracic oncologist, Northwestern University Feinberg School of Medicine, discusses the benefits of multidisciplinary approach for the treatment of patients with stage III disease.

Jyoti D. Patel, MD, thoracic oncologist, Northwestern University Feinberg School of Medicine, discusses the benefits of multidisciplinary approach for the treatment of patients with stage III disease.

All patients with stage III disease will receive chemotherapy, Patel says, and their medical oncologist will guide them through the process. There needs to be a conversation with a radiation oncologist regarding heart and lung toxicity and a conversation with a surgeon regarding resection.

<<<

View more from the 2014 Multidisciplinary Symposium in Thoracic Oncology

Related Videos
A panel of 5 experts on lung cancer
A panel of 5 experts on lung cancer
George R. Simon, MD, FACP, FCCP
Ashish Saxena, MD, PhD
Eric Vallieres, MD, FRCSC
Benjamin Levy, MD
Pasi A. Jänne, MD, PhD, discusses an exploratory analysis from the FLAURA2 trial of osimertinib plus chemotherapy in treatment-naive, EGFR-mutant NSCLC.